Established biomarkers, including hormone receptors (HR), estrogen receptor (ER), progesterone receptor (PR), human epidermal growth receptor-2(HER-2), and Ki67 labeling index classify breast cancer into four subtypes: HER2-enriched, triple-negative (TN), and Luminal A and B types [2,3]. Here, MKI67 is linked to breast carcinoma.